Spots Global Cancer Trial Database for Rapamycin With Grapefruit Juice for Advanced Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Rapamycin With Grapefruit Juice for Advanced Malignancies
Official Title: A Phase Ib Study Administering Rapamycin (Sirolimus) With Grapefruit Juice in Patients With Advanced Malignancies
Study ID: NCT00375245
Study Description
Brief Summary: The purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Chicago Hospitals, Chicago, Illinois, United States
Contact Details
Name: Ezra W Cohen, MD
Affiliation: University of Chicago
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
